Q&A: Graham DeLaet on stem cell treatment, Timbits, beer and Tiger – Sportsnet.ca
Sportsnet.ca |
Q&A: Graham DeLaet on stem cell treatment, Timbits, beer and Tiger
Sportsnet.ca DeLaet reveled on Twitter last week he had an intradiscal stem cell injection – he told Sportsnet.ca that the treatment occurred at a clinic in California – and he had yet to recover. It remains to be seen when he’ll be returning to action on the PGA … |
Scientific American |
The Pharma Exec behind the First Approved Gene Therapy Is Hunting for His Next Big Break
Scientific American Joseph Jimenez retires at the end of the month after eight years in the top job at Novartis, one of the world’s largest pharmaceutical companies. Under his leadership the company sold off its vaccine division and shifted its focus to developing generic … |
|
Advaxis’ Immunotherapy in Combination with Chemoradiation Highlighted as Potential Treatment for Anal Cancer in …
Business Wire (press release) PRINCETON, N.J.–(BUSINESS WIRE)–Advaxis, Inc. (NASDAQ:ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today announces that data from the investigator-initiated study … |
FierceBiotech |
Synpromics, UCL ally to aim gene therapies at blood-based diseases
FierceBiotech Synpromics has entered into another gene therapy collaboration with UCL. This time around the aim is to apply Synpromics’ synthetic promoter expertise to the development of gene therapies against diseases affecting blood production. Working with Adrian … Synpromics Announces New Partnership with UCL to Develop …Business Wire (press release) Gene therapy developer Synpromics signs collaboration deal …insider.co.uk Collaboration formed for development of novel gene therapies for …EPM Magazine |